Triple-Agonist GLP-1 / GIP / Glucagon

Buy Reta-Cagri

Name: Reta-Cagri
Brand: Peptides Looksmaxxing
SKU: PG-1099
Price: 134.99 USD
Availability: InStock

Not For Human Use, Lab Use Only.

Triple incretin/glucagon receptor pharmacology—listed here as a research-grade lyophilized SKU with supplier-stated purity.

$134.99In StockShop Now

≥98% Purity

HPLC Verified

Research Grade

Lyophilized

Fast Shipping

Free $200+

Specifications

CAS Number2381089-83-2

MechanismGLP-1 + GIP + Glucagon receptor agonist

Molecular Weight~5,766 Da

Storage−20°C (lyophilized) · 4°C in solution up to 4 weeks

Purity≥98% HPLC verified

FormLyophilized powder

Reta-Cagri — Signaling & Cellular Response

GLP-1 Receptor Agonism — Appetite & Insulin

Retatrutide activates GLP-1 receptors in the hypothalamus, reducing appetite and caloric intake. It also potentiates glucose-dependent insulin secretion and suppresses glucagon — the same pathway exploited by semaglutide, but as one component of a three-part mechanism.

GIP Receptor Agonism — Adipose & Insulin Sensitization

GIP receptor signaling is discussed in incretin pharmacology as influencing adipose and beta-cell biology alongside GLP-1. Mechanistic reviews are the right place for pathway detail; this page does not summarize comparative human weight-change outcomes.

Glucagon Receptor Agonism — Energy Expenditure

The glucagon receptor arm differentiates retatrutide from dual incretin designs in receptor coverage. Hepatic glucagon signaling is linked in the literature to glucose and lipid turnover; we do not quote human energy-balance or weight-loss deltas on this storefront.

Liver Signaling (Preclinical / Literature)

Published work discusses glucagon and GLP-1 family signaling in hepatic lipid handling; specific magnitudes and human outcome claims belong in primary literature, not on this catalog page.

Reta-Cagri — Catalog Disclaimer

This page summarizes identity, purity, and handling context for catalog navigation. It is not medical advice, a drug label, or a summary of clinical outcomes for any use. Materials are sold for legitimate laboratory research only; verify requirements with your institution and the supplier.

Buying Reta-Cagri: Vial Math & Handling

Figures below are volumetric / handling notes for lyophilized material only. They are not therapeutic dosing, efficacy claims, or instructions for use in humans or animals.

Protocol

Dose

Frequency

Notes

Subcutaneous Injection

2–12 mg/week

Once weekly

Illustrative weekly ranges sometimes discussed in scientific literature for this drug class—laboratory handling only; not a human protocol.

Low-Dose Entry

0.5–2 mg/week

Once weekly

Lower illustrated weekly ranges appear in some publications for titration discussions—reference only.

Compound note

Reta-Cagri — Dissolution Profile

10mg vial + 2mL BAC water = 5mg/mL (5,000 mcg/mL). Example draws: 0.8mL = 4mg; 1.6mL = 8mg—solution math only.

Retatrutide is a lipidated GLP-3 analog — allow 2–5 min of gentle swirling for full dissolution. Post-reconstitution stable at 2–8°C for 4 weeks.

Add Bacteriostatic Water — $8.99

Reta-Cagri — Pair This With

BPC-157

BPC-157 is commonly discussed in tissue-repair literature alongside metabolic research programs; pairing rationale here is descriptive, not an outcome claim.